Qualigen Therapeutics, Inc.
For the period ended Oct 20, 2025. Filed Oct 20, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Oct 20, 2025 · Filed Oct 20, 2025
Use the contents to explore the available documents and sections.
Contents
Cover page
Show cover page
DEF 14A 1 formdef14a.htm DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
(Name of Registrant as Specified In Its Charter)
Payment of Filing Fee (Check the appropriate box):
☒ No fee required.
☐ Fee paid previously with preliminary materials.
☐ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
Notice of Special Meeting of Stockholders
November 12, 2025
PLEASE VOTE TODAY
Dear Stockholders:
We cordially invite you to attend the Special Meeting of Stockholders (the “Special Meeting”) of Qualigen Therapeutics, Inc., a Delaware corporation (the “Company,” “we,” “our” or “us”), to be held on November 12, 2025, at 10:00 AM local time. The Special Meeting will be held in a virtual-only format via internet atwww.virtualshareholdermeeting.com/QLGN2025SM and entering the 16-digit control number included in your proxy materials, on your proxy card or in the instructions that accompanied your proxy materials.
Please see the “Questions and Answers about These Proxy Materials and Voting” in the accompanying Proxy Statement for more details.
The Special Meeting is being held for the following purposes:
| 1. | To approve, pursuant to Nasdaq Rule 5635(a) and (b), the transactions provided for in that certain Subscription Agreement dated September 19, 2025, between the Company and certain investors, and related agreements, including the issuance of 337,432 shares of the Company’s common stock and 39,943 shares of the Company’s Series B Convertible Preferred Stock sold in a private placement transaction (the “Offering”). |
| 2. | To approve, pursuant to Nasdaq Rule 5635(d), the issuance of shares of the Company’s common stock upon the conversion of the Series B Convertible Preferred Stock in excess of the 19.99% share exchange cap contained therein. |
| 3. | To approve the Company’s 2025 Equity Incentive Plan. |
| 4. | To approve adjournments or postponements of the Special Meeting or to transact such other business as may be properly brought before the Special Meeting. |
The Board recommends that you vote “FOR” Proposals 1, 2, 3, and 4 and has fixed the close of business on September 22, 2025, as the record date for the determination of stockholders who will be entitled to notice of and to vote at the Special Meeting. Further information regarding voting rights and the matters to be voted upon at the Special Meeting is presented in the accompanying Proxy Statement. A list of stockholders of record will be available for inspection at the Special Meeting and, during the 10 days prior to the Special Meeting, at our principal executive offices located at the address above.
Important Information
This Proxy Statement, with the enclosed proxy card, is being furnished to our stockholders in connection with the solicitation by our Board of proxies to be voted at our Special Meeting and at any postponements or adjournments thereof. The Company has filed with the SEC a proxy statement in connection with the Special Meeting and advises its stockholders to read the entirety of this Proxy Statement and any and all supplements and amendments thereto. This Proxy Statement and the enclosed proxy card are first being mailed to our stockholders on or about October 20, 2025.
Stockholders may obtain a free copy of This Proxy Statement and other documents filed by the Company with the SEC atwww.sec.gov. This Proxy Statement and proxy card are also available on the Company’s corporate website athttps://ir.qlgntx.com/sec-filings/.
By Order of the Board of Directors,
/s/ Kevin A. Richardson II
Kevin A. Richarson II
Co-Chief Executive Officer
Carlsbad, California
October 20, 2025
We have elected to utilize the “full set delivery”option and are delivering paper copies to all stockholders entitled thereto of all proxy materials, as well as providing access to those proxy materials on a publicly accessible website. Our proxy materials for the Special Meeting are being mailed to our stockholders on or about October 20, 2025. This Proxy Statement and proxy card will also be available to our stockholders atwww.proxyvote.com on that same date.
Whether or not you expect to attend the meeting electronically, please submit a proxy or voting instructions for your shares promptly using the directions in your proxy materials or on your proxy card, or, if you elected to receive printed proxy materials by mail, your proxy card, by one of the following methods: (1) over the internet by visitingwww.proxyvote.com and entering the 16-digit control number included in your proxy materials, (2) by telephone by calling the toll-free number 1-800-690-6903, or (3) by marking, dating, and signing your proxy card and returning it in the accompanying postage-paid envelope. Even if you have voted by proxy, you may still vote if you attend the meeting electronically. Please note, however, that if your shares are held of record by a broker, bank, or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder.
TABLE OF CONTENTS
| Page | |
|---|---|
| INTRODUCTION | 1 |
| QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING | 2 |
| BACKGROUND AND DESCRIPTION OF THE PRIVATE PLACEMENT | 6 |
| PROPOSAL 1 — THE OFFERING AND RELATED TRANSACTIONS PROPOSAL | 7 |
| PROPOSAL 2 — THE ISSUANCE PROPOSAL | 8 |
| PROPOSAL 3 — THE 2025 EQUITY INCENTIVE PLAN PROPOSAL | 9 |
| PROPOSAL 4 — THE ADJOURNMENT PROPOSAL | 10 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS | 11 |
| OTHER MATTERS | 12 |
| PROXY SOLICITATION AND COSTS | 12 |
| WHERE YOU CAN FIND MORE INFORMATION | 12 |
i
5857 Owens Avenue, Suite 300 Carlsbad, California 92008
PROXY STATEMENT
FOR
SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD AT 10:00 A.M. PACIFIC TIME ON NOVEMBER 12, 2025
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.